Clinical Trial

Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts

Study acronym: Legion Oxinium
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to collect data on patients that had the Legion CR Oxinium and CoCr Femoral Implant and the Legion/Genesis II XLPE High Flex Tibial Inserts implanted in the past. Smith \& Nephew will evaluate the safety and performance of these implants.
Protocol Amendment History 27 amendments
This ClinicalTrials.gov record has been amended 27 times since 2018-09-26; most recent amendment 2026-01-27.
Status change: Recruiting → Active, Not Recruiting 2019-09-24
Trial Details
NCT Number NCT03687593
Lead Sponsor Smith & Nephew, Inc.
Conditions Total Knee Arthroplasty
Enrollment 126 participants
Start Date 2018-08-26
Primary Completion 2027-10-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-29